Sale!

C21orf2 Gene Cone-Rod Dystrophy Genetic Test

Original price was: $700.Current price is: $500.

-29%

The C21orf2 Gene Cone-Rod Dystrophy NGS Genetic DNA Test is a cutting-edge genetic analysis that identifies mutations in the C21orf2 gene associated with cone-rod dystrophy, a progressive inherited retinal disorder. This comprehensive test utilizes next-generation sequencing (NGS) technology to detect specific genetic variants that cause vision loss, night blindness, and color vision impairment. Early detection through this $500 USD test enables proactive vision management, genetic counseling, and personalized treatment planning. The test is particularly valuable for individuals with family history of retinal disorders or those experiencing early symptoms of vision deterioration. Results provide crucial information for family planning and potential therapeutic interventions to preserve remaining vision.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

C21orf2 Gene Cone-Rod Dystrophy NGS Genetic DNA Test

Understanding Cone-Rod Dystrophy and C21orf2 Gene Testing

Cone-rod dystrophy represents a group of inherited retinal disorders characterized by progressive vision loss affecting both cone and rod photoreceptor cells. The C21orf2 gene, located on chromosome 21, plays a crucial role in retinal development and function. Mutations in this specific gene can lead to autosomal recessive cone-rod dystrophy, making genetic testing essential for accurate diagnosis and management.

What This Advanced Genetic Test Detects

Our comprehensive NGS-based genetic analysis specifically targets:

  • Pathogenic variants in the C21orf2 gene associated with cone-rod dystrophy
  • Single nucleotide polymorphisms (SNPs) affecting retinal function
  • Insertion/deletion mutations that disrupt normal gene expression
  • Copy number variations impacting photoreceptor cell health
  • Autosomal recessive inheritance patterns for family planning

Who Should Consider C21orf2 Genetic Testing?

Clinical Indications and Symptoms

This genetic test is recommended for individuals experiencing:

  • Progressive vision loss beginning in childhood or early adulthood
  • Difficulty with color discrimination and reduced visual acuity
  • Night blindness and photophobia (light sensitivity)
  • Family history of inherited retinal disorders
  • Abnormal electroretinogram (ERG) results indicating cone-rod dysfunction
  • Unexplained visual field defects or central vision loss

Significant Benefits of Early Genetic Diagnosis

Undergoing C21orf2 genetic testing provides numerous advantages:

  • Accurate Diagnosis: Confirms cone-rod dystrophy subtype for targeted management
  • Prognostic Information: Helps predict disease progression and visual outcomes
  • Family Planning: Enables informed reproductive decisions and genetic counseling
  • Treatment Guidance: Supports development of personalized vision preservation strategies
  • Clinical Trial Eligibility: Opens access to emerging retinal disease therapies
  • Psychological Relief: Reduces diagnostic uncertainty and provides clarity

Understanding Your Test Results

Interpretation Guidelines

Your genetic test results will fall into one of these categories:

  • Positive Result: Identifies pathogenic C21orf2 mutation confirming cone-rod dystrophy diagnosis
  • Negative Result: No detected mutations in C21orf2 gene, suggesting alternative causes
  • Variant of Uncertain Significance: Identifies genetic changes requiring further clinical correlation
  • Carrier Status: Identifies individuals with single mutation who may pass condition to offspring

All results include comprehensive genetic counseling to ensure proper understanding and next steps. Our certified genetic counselors help interpret findings within the context of your clinical presentation and family history.

Test Details and Pricing

Test Component Details
Test Name C21orf2 Gene Cone-Rod Dystrophy NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements and Preparation

Before scheduling your genetic test, we recommend:

  • Comprehensive clinical history documentation of retinal symptoms
  • Genetic counseling session to create detailed family pedigree chart
  • Discussion of potential implications for family members
  • Review of current ophthalmological findings and test results
  • Understanding of insurance coverage and potential out-of-pocket costs

Nationwide Accessibility and Convenience

GGC DNA maintains testing facilities across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures convenient access to advanced genetic testing regardless of your location.

Take Control of Your Vision Health Today

Early genetic diagnosis of cone-rod dystrophy can significantly impact your quality of life and vision preservation strategies. Our $500 genetic test provides definitive answers and empowers you to make informed healthcare decisions.

Ready to schedule your C21orf2 genetic test? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Our team is available to answer questions, discuss insurance coverage, and guide you through the testing process.

Don’t let uncertainty about your vision health continue. Take the first step toward clarity and personalized care with comprehensive C21orf2 genetic testing from GGC DNA – your trusted partner in genetic diagnostics.